GYRE THERAPEUTICS, INC. (GYRE)
Nasdaq: GYRE · CIK 0001124105 · United States
Every official GYRE THERAPEUTICS, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open GYRE filings
GYRE THERAPEUTICS, INC. documents
- GYRE THERAPEUTICS, INC. 10-K 2026GYRE 10-K 2026: annual report for fiscal 2026
- GYRE THERAPEUTICS, INC. 10-K 2025GYRE 10-K 2025: annual report for fiscal 2025
- GYRE THERAPEUTICS, INC. 10-K 2024GYRE 10-K 2024: annual report for fiscal 2024
- GYRE THERAPEUTICS, INC. 10-K 2023GYRE 10-K 2023: annual report for fiscal 2023
- GYRE THERAPEUTICS, INC. 10-K 2022GYRE 10-K 2022: annual report for fiscal 2022
- GYRE THERAPEUTICS, INC. 10-Q 2026GYRE 10-Q 2026: quarterly report for fiscal 2026
- GYRE THERAPEUTICS, INC. 10-Q 2025GYRE 10-Q 2025: quarterly report for fiscal 2025
- GYRE THERAPEUTICS, INC. 10-Q 2024GYRE 10-Q 2024: quarterly report for fiscal 2024
- GYRE THERAPEUTICS, INC. 10-Q 2023GYRE 10-Q 2023: quarterly report for fiscal 2023
- GYRE THERAPEUTICS, INC. 10-Q 2022GYRE 10-Q 2022: quarterly report for fiscal 2022
- GYRE THERAPEUTICS, INC. 8-K 2026GYRE 8-K 2026: current report for fiscal 2026
- GYRE THERAPEUTICS, INC. 8-K 2025GYRE 8-K 2025: current report for fiscal 2025
- GYRE THERAPEUTICS, INC. 8-K 2024GYRE 8-K 2024: current report for fiscal 2024
- GYRE THERAPEUTICS, INC. 8-K 2023GYRE 8-K 2023: current report for fiscal 2023
- GYRE THERAPEUTICS, INC. 8-K 2022GYRE 8-K 2022: current report for fiscal 2022
- GYRE THERAPEUTICS, INC. DEF 14A 2026GYRE DEF 14A 2026: proxy statement for fiscal 2026
- GYRE THERAPEUTICS, INC. DEF 14A 2025GYRE DEF 14A 2025: proxy statement for fiscal 2025
- GYRE THERAPEUTICS, INC. DEF 14A 2024GYRE DEF 14A 2024: proxy statement for fiscal 2024
- GYRE THERAPEUTICS, INC. DEF 14A 2023GYRE DEF 14A 2023: proxy statement for fiscal 2023
- GYRE THERAPEUTICS, INC. DEF 14A 2022GYRE DEF 14A 2022: proxy statement for fiscal 2022
- GYRE THERAPEUTICS, INC. Form 4 2026GYRE Form 4 2026: insider trading filing for fiscal 2026
- GYRE THERAPEUTICS, INC. Form 4 2025GYRE Form 4 2025: insider trading filing for fiscal 2025
- GYRE THERAPEUTICS, INC. Form 4 2024GYRE Form 4 2024: insider trading filing for fiscal 2024
- GYRE THERAPEUTICS, INC. Form 4 2023GYRE Form 4 2023: insider trading filing for fiscal 2023
- GYRE THERAPEUTICS, INC. Form 4 2022GYRE Form 4 2022: insider trading filing for fiscal 2022
- GYRE THERAPEUTICS, INC. S-1 2026GYRE S-1 2026: registration statement for fiscal 2026
- GYRE THERAPEUTICS, INC. S-1 2025GYRE S-1 2025: registration statement for fiscal 2025
- GYRE THERAPEUTICS, INC. S-1 2024GYRE S-1 2024: registration statement for fiscal 2024
- GYRE THERAPEUTICS, INC. S-1 2023GYRE S-1 2023: registration statement for fiscal 2023
- GYRE THERAPEUTICS, INC. S-1 2022GYRE S-1 2022: registration statement for fiscal 2022
- GYRE THERAPEUTICS, INC. 13F 2026GYRE 13F 2026: institutional holdings for fiscal 2026
- GYRE THERAPEUTICS, INC. 13F 2025GYRE 13F 2025: institutional holdings for fiscal 2025
- GYRE THERAPEUTICS, INC. 13F 2024GYRE 13F 2024: institutional holdings for fiscal 2024
- GYRE THERAPEUTICS, INC. 13F 2023GYRE 13F 2023: institutional holdings for fiscal 2023
- GYRE THERAPEUTICS, INC. 13F 2022GYRE 13F 2022: institutional holdings for fiscal 2022
More companies